L11
General Information
DRACP ID DRACP00063
Peptide Name L11
Sequence PAARKAARWAWRMLKKGA
Sequence Length 18
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane-targeted
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
Meth A | Mouse fibrosarcoma | Sarcoma | IC50=116 µM | MTT assay | 4 h | 1 |
MT-1 | Human mammary carcinoma | Carcinoma | IC50=75 µM | MTT assay | 4 h | 1 |
HT-29 | Colon adenocarcinoma | Carcinoma | IC50=248 µM | MTT assay | 4 h | 1 |
Hemolytic Activity Human red blood cells: EC50>480 µM
Normal (non-cancerous) Cytotoxicity Fibroblas: IC50>480 µM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antimicrobial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C94H154N32O19S
Absent amino acids CDEFHINQSTVY
Common amino acids A
Mass 237194
Pl 12.82
Basic residues 6
Acidic residues 0
Hydrophobic residues 9
Net charge 6
Boman Index -3768
Hydrophobicity -69.44
Aliphatic Index 55
Half Life
Mammalian: >20 hour
Yeast: >20 hour
E.coli: ?
Extinction Coefficient cystines 11000
Absorbance 280nm 647.06
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 12366526
Title Enhanced antitumor activity and selectivity of lactoferrin-derived peptides
Doi 10.1034/j.1399-3011.2002.21008.x
Year 2002
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available